Overexpression of miR-133b protects against isoflurane-induced learning and memory impairment

Yu Zhang1, Jinyong Liu1, Cuili Xie1

  • 1Department of Anesthesiology, Jining No. 1 People's Hospital, Jining, Shandong 272000, P.R. China.

Insights

MicroRNA-133b (miR-133b) protects against anesthesia-induced cognitive deficits. Overexpressing miR-133b in rats improved learning and memory, while reducing neuronal damage and apoptosis caused by isoflurane exposure.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Anesthesiology

Background:

  • Anesthesia can induce cognitive impairment, a process involving microRNAs (miRs).
  • Specific miRs are implicated in regulating anesthesia-induced cognitive dysfunction.
  • Understanding the role of individual miRs is crucial for developing interventions.

Purpose of the Study:

  • To investigate the role of microRNA-133b (miR-133b) in isoflurane-induced learning and memory impairment.
  • To elucidate the underlying mechanisms of miR-133b's action in the hippocampus.

Main Methods:

  • Established a rat model of isoflurane exposure.
  • Assessed spatial learning and memory using the Morris water maze (MWM) test.
  • Measured miR-133b expression via reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
  • Evaluated cell viability (Cell Counting Kit-8) and apoptosis (flow cytometry) in primary hippocampal neurons.

Main Results:

  • Isoflurane exposure impaired spatial learning and memory in rats, evidenced by increased MWM training time and probe trial escape latency.
  • Overexpression of miR-133b significantly attenuated isoflurane-induced cognitive deficits.
  • In vitro studies showed miR-133b protected hippocampal neurons from isoflurane-induced viability reduction and apoptosis.

Conclusions:

  • MicroRNA-133b overexpression mitigates learning and memory impairment caused by isoflurane anesthesia.
  • miR-133b enhances hippocampal neuron viability and apoptosis resistance under isoflurane exposure.
  • miR-133b represents a potential therapeutic target for preventing anesthesia-related cognitive dysfunction.